Treatment FAQ

what is a treatment in a research study

by Danielle Collier Published 3 years ago Updated 2 years ago
image

Treatment groups are the sets of participants in a research study that are exposed to some manipulation or intentional change in the independent variable of interest. They are an integral part of experimental research design that helps to measure effects as well as establish causality.Dec 19, 2018

Full Answer

What is a clinical research study?

The idea for a clinical research study-also known as a clinical trial-often starts in the laboratory. After researchers test new therapies or procedures in the laboratory and in animal studies, the most promising experimental treatments are moved into clinical trials, which are conducted in phases.

What is the purpose of drug research?

to determine whether a new drug or device is safe and effective for people to use. to study different ways to use standard treatments or current, approved treatments so that they will be more effective, easier to use, or decrease certain side effects.

What are the two types of research studies?

There are two types, observational studies and clinical trials. Observational studies observe people in normal settings. Researchers gather information, group volunteers according to broad characteristics, and compare changes over time.

What is a treatment?

The word treatment appears many times in the typical text on statistics and/or research design. It appears frequently in the indices of such texts. It is rarely defined. It is defined here, and how the term is used by researchers is shown.

image

What is the example of treatment in research?

and the “treatment” is the variable you are studying. For example, a human experimental group could receive a new medication, a different form of counseling, or some vitamin supplements. A plant treatment group could receive a new plant fertilizer, more sunlight, or distilled water.

What does treatments mean in an experiment?

In terms of the experiment, we need to define the following: Treatment: is what we want to compare in the experiment. It can consist of the levels of a single factor, a combination of levels of more than one factor, or of different quantities of an explanatory variable.

What is treatment of the data in research?

What is Statistical Treatment of Data? Statistical treatment of data is when you apply some form of statistical method to a data set to transform it from a group of meaningless numbers into meaningful output.

What is a treatment in design?

Treatments are administered to experimental units by 'level', where level implies amount or magnitude. For example, if the experimental units were given 5mg, 10mg, 15mg of a medication, those amounts would be three levels of the treatment.

What is the definition of treatment in statistics?

0:004:15In this video i'll explain what a statistical treatment is i'll show you what it means for dataMoreIn this video i'll explain what a statistical treatment is i'll show you what it means for data analysis i'll show you how to choose a statistical test and i'll also explain what statistical

How do I choose a statistical treatment?

Selection of appropriate statistical method depends on the following three things: Aim and objective of the study, Type and distribution of the data used, and Nature of the observations (paired/unpaired).

What is a treatment variable in statistics?

the independent variable, whose effect on a dependent variable is studied in a research project.

Why treatment of data is important in research?

The correct treatment of data in research is important in maintaining the authenticity, reliability, and accuracy of the research. Inaccurate treatment of data can be done in many forms and in different intensity. A data that has been totally altered or produced without any real experiments is called a fraudulent data.

What is the treatment structure?

Such information pertaining to treatments is called the TREATMENT STRUCTURE of the experiment. To minimize systematic bias, the treatments (or treatment combinations) are usually applied according to a randomization scheme.

What is treatment structure in experimental design?

Treatment Structure. The set of treatments or treatment combinations that the investigator has selected to study and/or compare. Design Structure. The grouping of experimental units into homogenous groups; often referred to as the blocking criterion.

What does treatment mean in Anova?

In the context of an ANOVA, a treatment refers to a level of the independent variable included in the model.

What is experimental research?

In experimental research, the researcher manipulates the independent or treatment variable (s) and then observes whether the treatment groups differ on one or more dependent or outcome variables. In multiple-case research, the scores of two or more groups of cases (which might be the same research units or might be ...

What is multiple case research?

In multiple-case research, the scores of two or more groups of cases (which might be the same research units or might be ...

What is clinical research?

Clinical research is much different from the medical treatment you receive in a Healthcare Provider's office. Answers specific questions through research involving numerous research volunteers. Address the needs of individual patients.

Where does a clinical research study start?

The idea for a clinical research study—also known as a clinical trial—often starts in the laboratory. After researchers test new therapies or procedures in the laboratory and in animal studies, the most promising experimental treatments are moved into clinical trials, which are conducted in phases. During a trial, more information is gained about ...

How does the FDA work?

FDA works to protect participants in clinical trials and to ensure that people have reliable information before deciding whether to join a clinical trial. The Federal government has regulations and guidelines for clinical research to protect participants from unreasonable risks.

What does the FDA do?

FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials. Learn more about FDA’s efforts to increase diversity in clinical trials.

Why is confidentiality important in clinical research?

Confidentiality is an important part of clinical research and ensures that personal information is seen only by those authorized to have access. It also means that the personal identity and all medical information of clinical trial participants is known only to the individual patient and researchers.

How to find out if there are clinical trials?

One good way to find out if there are any clinical trials that might help you is to ask your doctor. Other sources of information include:

What are the criteria for clinical trials?

All clinical trials have guidelines, called eligibility criteria, about who can participate. The criteria are based on such factors as age, sex, type and stage of disease, previous treatment history, and other medical conditions.

Before you search

Every patient has the right to know about all of their options for care, including clinical trials and research. Your doctor may not be aware of all the research opportunities available to you, especially if she practices at a hospital or facility that is not enrolling patients in a study.

Medical information you may need

It is helpful to have your medical records, especially your pathology report on hand as you search for treatment clinical trials.

Beginning your search

Cancers can also be categorized by stage . Stage refers to a set of criteria that experts use to determine how far a cancer has spread in order to recommend the best treatment for a patient. Cancer treatment clinical trials are often open only to people with a particular cancer stage.

Study features

Study design describes different features of a clinical trial, including:

Searching breast cancer treatment studies

Our Research Study Search Tool helps you find breast cancer studies by:

Searching ovarian cancer treatment studies

Ovarian cancer studies are open to people with an inherited mutation associated with increased cancer risk, including BRCA1, BRCA2, Lynch Syndrome BRIP1, RAD51C, RAD51D, STK11 and other genes RAD51D .

Searching pancreatic cancer treatment studies

You can search pancreatic cancer treatment studies in our matching tool by:

What is the purpose of data from a naturalistic, longitudinal international treatment study of DD patients and their therapist?

Data from a naturalistic, longitudinal international treatment study of DD patients and their therapists were analyzed to determine if the alliance , as reported by patients and therapists, was associated with treatment outcome.

Why is the therapeutic alliance important?

Abstract: Research has shown that the therapeutic alliance plays an important role in enhancing treatment outcome among individuals with a variety of disorders, including posttraumatic stress disorder (PTSD). However, the therapeutic alliance and treatment outcome has not yet been studied in dissociative disorders (DD).

Do dissociative identity disorders respond well to treatment?

Conclusion: Our findings, though preliminary, provide empirical validation of previous clinical impressions that patients with dissociative identity disorder may respond well to treatment.

Is trauma focused psychotherapy harmful?

The claims that DID treatment is harmful are based on anecdotal cases, opinion pieces, reports of damage that are not substantiated in the scientific literature, misrepresentations of the data, and misunderstandings about DID treatment and the phenomenology of DID. Given the severe symptomatology and disability associated with DID, iatrogenic harm is far more likely to come from depriving DID patients of treatment that is consistent with expert consensus, treatment guidelines, and current research.

What is the treatment discovery process?

The treatment discovery process is an iterative process of studying a disease, hypothesizing and developing treatments, evaluating those treatments, and, for successful treatments, further refining the indication to account for lack of efficacy or toxicities (or both) in particular subgroups of patients. As a rule, the scientific development of a particular treatment indication is often connected with that of other treatments, and thus it may be difficult to identify the exact process that led to the adoption of some treatment. Nevertheless, the following describes a general chronology of events.

What is the desired outcome of a treatment?

The Desired OutcomeThe intended outcome of a treatment is typicallycharacterized clinically, as outcomes that materially affect the clinical manifestations of the disease (e.g., lower risk of mortality, relief of symptoms, improvement in quality of life). In some settings, a strong risk factor thought to represent a surrogate outcome measure of subclinical disease or disease risk will be used (e.g., hypertension). The distinction between surrogate and clinical outcomes depends on the degree to which a patient’s sense of well-being is directly related to the outcome or the degree to which it is known that any modifications in the biomarker might possibly not be associated with an improvement in the clinical outcome (i.e., treating the symptom but not the disease). The precise definition of the outcome might explicitly include the time frame of measurement (e.g., postprandial serum glucose levels) and the method of measurement (e.g., decreasing serum glucose levels as reflected in Hemoglobin A1c), or the time frame might only be implicitly defined.

What is intervention in medicine?

The InterventionAn intervention consists of a formulation of the drug(s)or device(s), a mode of administration, the dosing strategy, auxiliary treatments, and the duration of treatment. Some treatments are combinations of drugs, either in a common formulation or administered separately. A mode of administration can include topical, oral, subcutaneous, intramuscular, or intravenous. In some circumstances the mode of administration may even stipulate special training for the person administering the treatment. The dose may be specified as a common level to be used by all individuals or as a dose specific to patient body size or body surface area. The dosing strategy might include a gradual increase in dose as treatment is initiated, a tapering of dose as the patient is weaned from the therapy, a regimen for increasing or decreasing the dose in response to observed patient conditions at the time of dosing (e.g., serum glucose in insulin therapy) or observed patient response to therapy (e.g., increasing the dose if the effect is not optimal or decreasing the dose in the presence of treatment toxicity).

What is phase 2 clinical trial?

Phase IIclinical trials seek further safety data and preliminary evidence in support of biological effect. A slightly larger sample of subjects are administered the treatment at a dose or doses that were preliminarily judged safe in the phase I studies. Safety data are collected in a systematic fashion, including specified monitoring of any potential side effects that were identified previously. Phase II studies also serve to screen for treatments that show some sign of biological effect, such as a biological marker that is a surrogate for the clinical outcome that is of interest. Products that fail to demonstrate a certain level of biological activity might be abandoned. Such a screening process is more efficient than other approaches in finding effective treatments from a large population of ideas.

What is toxicology in medicine?

toxicology, measuring the effect of dose on histopathologic lesions in major organ systems;

What is the term for the measurement of the effect of dose on the rate of absorption and excretion of drugs?

pharmacokinetics , measuring the effect of dose on rates of absorption and excretion of drugs from various body compartments;

What is aneffective treatment?

Aneffectivetreatment is one that provides improvement in the general health of the population viewed as a whole. Anefficacioustreatment is one that in some identifiable subpopulation results in an outcome judged more beneficial than that which would exist without treatment. An efficacious treatment may not be effective owing either to its inability to be administered safely in a broad population or to its effect on other aspects of patient treatment and behaviors beyond the outcome used to evaluate efficacy.

What is clinical research?

Clinical research is medical research involving people. There are two types, observational studies and clinical trials.

Why do we use clinical trials?

Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment. Other clinical trials test ways to find a disease early, sometimes before there are symptoms. Still others test ways to prevent a health problem.

What does the FDA do before a clinical trial?

Before the U.S. Food and Drug Administration (FDA) approves a clinical trial to begin, scientists perform laboratory tests and studies in animals to test a potential therapy’s safety and efficacy. If these studies show favorable results, the FDA gives approval for the intervention to be tested in humans.

How many phases are there in clinical trials?

Clinical trials advance through four phases to test a treatment, find the appropriate dosage, and look for side effects. If, after the first three phases, researchers find a drug or other intervention to be safe and effective, the FDA approves it for clinical use and continues to monitor its effects. Clinical trials of drugs are usually described ...

Why do we need older people in clinical trials?

Researchers need the participation of older people in their clinical trials so that scientists can learn more about how the new drugs, therapies, medical devices, surgical procedures, or tests will work for older people. Many older people have special health needs that are different from those of younger people. For example, as people age, their bodies may react differently to drugs. Older adults may need different dosages (or amounts) of a drug to have the right result. Also, some drugs may have different side effects in older people than younger people. Having seniors enrolled in drug trials helps researchers get the information they need to develop the right treatment for older people.

Why are seniors enrolled in drug trials?

Having seniors enrolled in drug trials helps researchers get the information they need to develop the right treatment for older people. Share this infographic and help spread the word about the benefits of participating in clinical trials and studies.

Why is it important to have participants of different ages, sexes, races, and ethnicities?

It is important for clinical trials to have participants of different ages, sexes, races, and ethnicities. When research involves a group of people who are similar, the findings may not apply to or benefit everyone. When clinical trials include diverse participants, the study results may have a much wider applicability.

What are the different types of research studies?

The five types of studies are discussed below. 1. Case Studies. Case studies look at a single subject (e.g., a child with autism) or a single case (e.g., a classroom for children with autism). Case studies are typically used in research ...

What is clinical trial?

Clinical trial studies are one specific type of randomized group experimental study. Clinical trial studies are most likely to be conducted in medical or other clinical settings. Similar to experimental group design studies, clinical trial studies employ an experimental/control group, in which participants are randomly assigned to receive the experimental treatment (e.g., a medication to treat autism symptoms) or a placebo (a sugar pill).

Why are participants not informed about their group assignment?

In both randomized experimental group and clinical trial studies, participants are not informed about their group assignment to guard against participant expectations about intervention or treatment. In addition, in well-designed studies, experimenters are not informed about group assignment either to guard against researcher expectations about intervention or treatment. That is, if participants expect to get better because they know they are receiving treatment, they may actually get better; similarly, if researchers expect an intervention to be successful, they may perceive it as so, regardless of whether or not the treatment is actually effective! This uninformed state is what researchers refer to as being blind to the conditions of the experiment. When both participants and experimenters are uninformed, it is referred to as a double-blind study, and is a means of ensuring objective results.

What are the two types of experimental studies?

Two primary types of experimental studies are used in intervention development and testing: randomized group design and single-case design.

What are the disadvantages of correlational studies?

The disadvantage of correlational studies is that it is not possible to control other factors outside of the study that might influence the research.

What is the first type of experimental group?

The first type includes experimental group designs in which participants are randomly assigned either to receive the intervention (the experimental group) or to a control group. The control group completes all the same steps as the experimental group, except they do not receive the intervention that is under investigation. Therefore, if the study is well controlled, it can be concluded that the differences between the experimental and control groups at the end of the study are due to the intervention.

What is SCD in research?

A second type of experimental study frequently used in intervention research is single-case design (SCD). Many studies involving children with autism, particularly those examining behavioral and educational treatments, use single-case designs. Rather than examining differences across participant groups that do and do not receive an intervention, single-case designs involve individual participants or a small cluster of participants who provide their own control for comparison. For example, a researcher may be interested in determining whether a new communication intervention tool on tablet devices improves communication skills.

Why do we do clinical trials?

Clinical trials are conducted for many reasons: 1 to determine whether a new drug or device is safe and effective for people to use. 2 to study different ways to use standard treatments or current, approved treatments so that they will be more effective, easier to use, or decrease certain side effects. 3 to learn how to safely use a treatment in a population for which the treatment was not previously tested, such as children.

Why do people participate in clinical trials?

Some people participate in clinical trials because none of the standard (approved) treatment options have worked, or they are unable to tolerate certain side effects. Clinical trials provide another option when standard therapy has failed.

How does the FDA work?

FDA works to protect participants in clinical trials and to ensure that people have reliable information before deciding whether to join a clinical trial. The Federal government has regulations and guidelines for clinical research to protect participants from unreasonable risks.

What is a protocol in clinical research?

Clinical trials are conducted according to a plan, called a protocol, which describes: what the researchers hope to learn from the study. Volunteers who participate in the study must agree to the rules and terms outlined in the protocol. Similarly, researchers, doctors, and other health professionals who manage the clinical trials must follow ...

What does the FDA do?

FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials. Learn more about FDA’s efforts to increase diversity in clinical trials.

How to find out if there are clinical trials?

One good way to find out if there are any clinical trials that might help you is to ask your doctor. Other sources of information include:

What are the criteria for clinical trials?

All clinical trials have guidelines, called eligibility criteria, about who can participate. The criteria are based on such factors as age, sex, type and stage of disease, previous treatment history, and other medical conditions.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9